Contact:Cannabis Science, Inc.President and CEODr. Robert J. Melamede, 888-889-0888 email@example.comVP of Investor Relations Robert Kane, 561-234-6929 firstname.lastname@example.org www.cannabisscience.comSOURCE Cannabis Science, Inc.
Everyone else is doing it.
Openfolio surveyed the portfolios of its pool of over 20,000 investors to see the effect penny stocks have on overall performance.
Researchers complain the pot the government now supplies is of poor quality. The government contract is open for bidding, but growers say the hurdles are insurmountable.